Hybrid Value-Aware Transformer Identifies Novel and Suspected Drugs for Alzheimer’s Disease

Abstract

Drug discovery for Alzheimer’s disease and related dementias (ADRD) faces many challenges including the complex and multifactorial nature of ADRD. Our research team developed the Hybrid Value-Aware Transformer (HVAT), a novel deep learning architecture designed to model multimodal health data.